Welcome to the central hub for all our articles and resources. Explore and stay connected with the latest updates of Act for Hope.
“Technology is only as powerful as the mission it serves: Patient access” We’re launching our Member Spotlight Series with Alexander…
Act for Hope Involved in the Launch of the ISCT Cell Therapy Leadership Training Program 2025 The ISCT…
Hope in Action: Monthly Update Each month, we share highlights from across our workstreams and how they’re helping…
Empowering patients, advocates, and organisations with a shared view of the cell and gene therapy (CGT) ecosystem isn’t just a…
There’s incredible work happening across the CGT ecosystem, but too often, it’s happening in isolation. A connected portal can turn…
In the cell and gene therapy space, the promise of innovation means little if patients can’t access treatments when they…
As cell and gene therapies transition from niche innovations to mainstream treatment options, the challenge is no longer just scientific,…
In today’s fast-paced world of drug development, no company can afford to work in isolation. The pharmaceutical industry has entered…
Collaboration and knowledge sharing are central drivers of innovation within India’s growing biotechnology sector. As multinational pharmaceutical companies form deeper…
Access to cell and gene therapies shouldn’t depend on where a patient lives or how well initiatives are connected. When…
A recent study examines how knowledge sharing shapes employee innovative behavior within the pharmaceutical logistics industry, a sector where operational…
In our latest blog, we explore a powerful conversation that is gaining momentum across the cell and gene therapy landscape:…
Access to advanced therapies isn’t just a clinical challenge it’s a systemic one. As cell and gene therapies move from…
When payers and accreditation bodies align early, everyone benefits, especially patients. Our work with accreditation frameworks aims to build those…
Accreditation is essential for ensuring patient safety and maintaining high standards of care, but it shouldn’t become a barrier to…
Why did we start Act for Hope? In this short fireside conversation, our founder Alexander Seyf reflects on the origins…
CGT manufacturing progress is often slowed by fragmented data environments, inconsistent documentation practices, and limited mechanisms for standardized data sharing…
Manufacturers in the CGT space often work through similar scientific and operational challenges independently, which leads to duplicated effort, slower…
As an increasing number of cell and gene therapies advance toward commercial scale, the industry is coming to understand that…
Every time we solve the same problem in isolation, we delay patient access. In this piece, Alexander Seyf,…
“Ring That Bell” – A Story of Resilience, Advocacy, and Innovation “Ring That Bell” brings together Irish musician Mags McCarthy…
Copyright© Act for hope 2026. Creation and eco-design DIOQA
